Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach

Today, the tool that is most commonly used to evaluate the osteogenic differentiation of bone marrow stromal cells (BMSCs) in vitro is the demonstration of the expression of multiple relevant markers, such as ALP, RUNX2 and OCN. However, as yet, there is no single surface marker or panel of markers...

Full description

Bibliographic Details
Main Authors: Cecilia Granéli, Anna Thorfve, Ulla Ruetschi, Helena Brisby, Peter Thomsen, Anders Lindahl, Camilla Karlsson
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506113001359
_version_ 1818543190678962176
author Cecilia Granéli
Anna Thorfve
Ulla Ruetschi
Helena Brisby
Peter Thomsen
Anders Lindahl
Camilla Karlsson
author_facet Cecilia Granéli
Anna Thorfve
Ulla Ruetschi
Helena Brisby
Peter Thomsen
Anders Lindahl
Camilla Karlsson
author_sort Cecilia Granéli
collection DOAJ
description Today, the tool that is most commonly used to evaluate the osteogenic differentiation of bone marrow stromal cells (BMSCs) in vitro is the demonstration of the expression of multiple relevant markers, such as ALP, RUNX2 and OCN. However, as yet, there is no single surface marker or panel of markers which clearly defines human BMSCs (hBMSCs) differentiating towards the osteogenic lineage. The aim of this study was therefore to examine this issue. Stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics was utilized to investigate differently expressed surface markers in osteogenically differentiated and undifferentiated hBMSCs. Labeled membrane proteins were analyzed by mass spectrometry (MS) and 52 proteins with an expression ratio above 2, between osteogenically differentiated and undifferentiated cells, were identified. Subsequent validation, by flow cytometry and ELISA, of the SILAC expression ratios for a number of these proteins and investigations of the lineage specificity of three candidate markers were performed. The surface markers, CD10 and CD92, demonstrated significantly increased expression in hBMSCs differentiated towards the osteogenic and adipogenic lineages. In addition, there was a slight increase in CD10 expression during chondrogenic differentiation. Furthermore, the expression of the intracellular protein, crystalline-αB (CRYaB), was only significantly increased in osteogenically differentiated hBMSCs and not affected during differentiation towards the chondrogenic or adipogenic lineages. It has been concluded from the present results that CD10 and CD92 are potential markers of osteogenic and adipogenic differentiation and that CRYaB is a potential novel osteogenic marker specifically expressed during the osteogenic differentiation of hBMSCs in vitro.
first_indexed 2024-12-11T22:32:05Z
format Article
id doaj.art-89f802ccf5b7420582cc519f398637f7
institution Directory Open Access Journal
issn 1873-5061
1876-7753
language English
last_indexed 2024-12-11T22:32:05Z
publishDate 2014-01-01
publisher Elsevier
record_format Article
series Stem Cell Research
spelling doaj.art-89f802ccf5b7420582cc519f398637f72022-12-22T00:48:05ZengElsevierStem Cell Research1873-50611876-77532014-01-0112115316510.1016/j.scr.2013.09.009Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approachCecilia Granéli0Anna Thorfve1Ulla Ruetschi2Helena Brisby3Peter Thomsen4Anders Lindahl5Camilla Karlsson6Department of Biomaterials, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, SwedenDepartment of Biomaterials, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, SwedenDepartment of Clinical Chemistry and Transfusion Medicine, Sahlgrenska Academy at The University of Gothenburg, SwedenBIOMATCELL, VINN Excellence Center of Biomaterials and Cell Therapy, Gothenburg, SwedenDepartment of Biomaterials, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, SwedenBIOMATCELL, VINN Excellence Center of Biomaterials and Cell Therapy, Gothenburg, SwedenDepartment of Biomaterials, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, SwedenToday, the tool that is most commonly used to evaluate the osteogenic differentiation of bone marrow stromal cells (BMSCs) in vitro is the demonstration of the expression of multiple relevant markers, such as ALP, RUNX2 and OCN. However, as yet, there is no single surface marker or panel of markers which clearly defines human BMSCs (hBMSCs) differentiating towards the osteogenic lineage. The aim of this study was therefore to examine this issue. Stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics was utilized to investigate differently expressed surface markers in osteogenically differentiated and undifferentiated hBMSCs. Labeled membrane proteins were analyzed by mass spectrometry (MS) and 52 proteins with an expression ratio above 2, between osteogenically differentiated and undifferentiated cells, were identified. Subsequent validation, by flow cytometry and ELISA, of the SILAC expression ratios for a number of these proteins and investigations of the lineage specificity of three candidate markers were performed. The surface markers, CD10 and CD92, demonstrated significantly increased expression in hBMSCs differentiated towards the osteogenic and adipogenic lineages. In addition, there was a slight increase in CD10 expression during chondrogenic differentiation. Furthermore, the expression of the intracellular protein, crystalline-αB (CRYaB), was only significantly increased in osteogenically differentiated hBMSCs and not affected during differentiation towards the chondrogenic or adipogenic lineages. It has been concluded from the present results that CD10 and CD92 are potential markers of osteogenic and adipogenic differentiation and that CRYaB is a potential novel osteogenic marker specifically expressed during the osteogenic differentiation of hBMSCs in vitro.http://www.sciencedirect.com/science/article/pii/S1873506113001359
spellingShingle Cecilia Granéli
Anna Thorfve
Ulla Ruetschi
Helena Brisby
Peter Thomsen
Anders Lindahl
Camilla Karlsson
Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach
Stem Cell Research
title Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach
title_full Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach
title_fullStr Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach
title_full_unstemmed Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach
title_short Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach
title_sort novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach
url http://www.sciencedirect.com/science/article/pii/S1873506113001359
work_keys_str_mv AT ceciliagraneli novelmarkersofosteogenicandadipogenicdifferentiationofhumanbonemarrowstromalcellsidentifiedusingaquantitativeproteomicsapproach
AT annathorfve novelmarkersofosteogenicandadipogenicdifferentiationofhumanbonemarrowstromalcellsidentifiedusingaquantitativeproteomicsapproach
AT ullaruetschi novelmarkersofosteogenicandadipogenicdifferentiationofhumanbonemarrowstromalcellsidentifiedusingaquantitativeproteomicsapproach
AT helenabrisby novelmarkersofosteogenicandadipogenicdifferentiationofhumanbonemarrowstromalcellsidentifiedusingaquantitativeproteomicsapproach
AT peterthomsen novelmarkersofosteogenicandadipogenicdifferentiationofhumanbonemarrowstromalcellsidentifiedusingaquantitativeproteomicsapproach
AT anderslindahl novelmarkersofosteogenicandadipogenicdifferentiationofhumanbonemarrowstromalcellsidentifiedusingaquantitativeproteomicsapproach
AT camillakarlsson novelmarkersofosteogenicandadipogenicdifferentiationofhumanbonemarrowstromalcellsidentifiedusingaquantitativeproteomicsapproach